Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0241 | ||||
Gene Name | SLC27A4 | ||||
Protein Name | Long-chain fatty acid transport protein 4 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | ACSVL4; FATP-4; FATP4; Fatty acid transport protein 4; IPS; SLC27A4; Solute carrier family 27 member 4 | ||||
DT Family | Fatty Acid Transporter (FAT) Family ; | ||||
Tissue Specificity | Expressed at highest levels in brain, testis,colon and kidney. Expressed at medium levels in heart and liver,small intestine and stomach. Expressed at low levels in peripheralleukocytes, bone marrow, skeletal muscle and aorta. Expressed inadipose tissue. | ||||
Function | This transporter mediates the transport of long chain fatty acids (LFCA) through plasma membrane. It seems to be the main fatty acid transporter in small intestinal cells. It plays a role in the formation of epidermal barrier. Essential for fat absorption in early embryo. | ||||
Endogenous Substrate(s) | Fatty acids | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.